Wellington Shields Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Wellington Shields Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,359	Closed	-$271K	–	375
2014 Q4	$271K	Sell	2,359 -6,495	-73%	-$787K	0.04%	285
2014 Q3	$1.38M	Sell	8,854 -4,695	-35%	-$681K	0.23%	95
2014 Q2	$1.67M	Sell	13,549 -150	-1%	-$16.6K	0.26%	75
2014 Q1	$1.42M	Buy	13,699 +745	+6%	+$76.3K	0.24%	80
2013 Q4	$1.17M	Hold	12,954	–	–	0.21%	97
2013 Q3	$866K	Buy	12,954 +100	+0.8%	+$6.89K	0.17%	129
2013 Q2	$850K	Buy	+12,854	New	+$735K	0.15%	140

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Shields Capital Management's SLXP Position: Q1 2015 in Review

Wellington Shields Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 2,359 shares — an estimated $271K sold.

Wellington Shields Capital Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $1.67M in Q2 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Wellington Shields Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Wellington Shields Capital Management sold 2,359 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $271K.
Wellington Shields Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Wellington Shields Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.67M in Q2 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Wellington Shields Capital Management's 13F filing for Q1 2015, filed 21 May 2015.